|
Code
|
83303
|
|
MA number
|
EU/1/09/546/004
|
|
Product Form:
|
sol iru 3(3x1)x0,5 ml/50 mg (striek.napl.skl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Janssen Biologics B.V., Netherland
|
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
|
ATC:
|
| L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| L04 |
Immunosuppressants |
| L04A |
Immunosuppressants |
| L04AB |
Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| L04AB06 |
Golimumab |
|
|
Shelf life:
|
24 |
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
